Skip to search formSkip to main contentSkip to account menu

Lederle

Known as: Lederle [Inactive - use WAL] 
National Institutes of Health

Related topics

Related topics

1 relation
Healthcare Industry

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Vero cells infected with the Lederle strain of canine distemper virus have increased Fas receptor signaling expression at 15 h post-infection.
We evaluated the expression of the Fas receptor gene in Vero cells infected with the Lederle vaccine strain of canine distemper… 
2002
2002
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine
Background. Pneumococcal polysaccharide/protein conjugate vaccines (PnCV) are immunogenic and effective in infancy. However, an… 
2002
2002
Clinical Implications of Endotoxin Concentrations in Vaccines
BACKGROUND: A previous study suggested that high concentrations of endotoxin may be present in whole-cell diphtheria/tetanus… 
Review
1999
Review
1999
The development of immunosuppressive therapy: from leukemia to transplantation.
1997
1997
Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP…
Severe adverse events were evaluated in a comparative efficacy trial in Germany in infants who received either the Lederle/Takeda… 
1992
1992
Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988.
1991
1991
Clinical trials in the United States and Japan with the Lederle-Takeda and Takeda acellular pertussis-diphtheria-tetanus (APDT) vaccines. The Multicenter APDT Vaccine Study Groups.
The results of the following studies are reported: a longitudinal double blind trial comparing Lederle-Takeda APDT vaccine with… 
1964
1964
PERSISTENCE OF ANTIBODY AFTER ORAL TRIVALENT POLIOVIRUS VACCINE (SABIN STRAINS).
BECAUSE of the favorable rates of serum-antibody conversion obtained in a pilot study in Elkins, West Virginia, with two feedings… 
1962
1962
Experience with measles immunization. Alum-absorbed killed measles-virus vaccine and live measles-virus vaccine challenge.
This report deals with the evaluation of a killed alum-adsorbed measles-virus vaccine, No. CT-1199E, prepared in the laboratories… 
1950
1950
Utilization of homocystine for growth in presence of vitamin B12 and folic acid.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)